Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE A DAVIS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1346210887
CMS profile
287142
Location
WILMINGTON, DE

General Payments · PY2018–2024

$2,283.01

  • Reported across 142 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$506.58

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $506.58 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $321.33 25
PY2019 $237.65 18
PY2020 $116.15 7
PY2021 $458.67 28
PY2022 $428.51 19
PY2023 $214.12 11
PY2024 $506.58 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.33 04/05/2024 Food and Beverage Undisputed 01/23/2026 1111559438 CMS
Amgen Inc. $20.07 05/03/2024 Food and Beverage Undisputed 01/23/2026 1117234861 CMS
Amgen Inc. $18.28 10/11/2024 Food and Beverage Undisputed 01/23/2026 1117234863 CMS
AstraZeneca Pharmaceuticals LP $18.62 02/02/2024 Food and Beverage Undisputed 01/23/2026 1105546169 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.50 02/08/2024 Food and Beverage Undisputed 01/23/2026 1117971325 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.25 05/01/2024 Food and Beverage Undisputed 01/23/2026 1117971331 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 08/28/2024 Food and Beverage Undisputed 01/23/2026 1117971329 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.80 09/30/2024 Food and Beverage Undisputed 01/23/2026 1117971327 CMS
E.R. Squibb & Sons, L.L.C. $22.35 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101310841 CMS
GlaxoSmithKline, LLC. $24.79 02/05/2024 Food and Beverage Undisputed 01/23/2026 1116093349 CMS
Novartis Pharmaceuticals Corporation $13.30 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086893197 CMS
Novartis Pharmaceuticals Corporation $3.38 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086893199 CMS
Novartis Pharmaceuticals Corporation $21.21 02/23/2024 Food and Beverage Undisputed 01/23/2026 1086893213 CMS
Novartis Pharmaceuticals Corporation $10.93 03/12/2024 Food and Beverage Undisputed 01/23/2026 1086893215 CMS
Novartis Pharmaceuticals Corporation $16.18 03/22/2024 Food and Beverage Undisputed 01/23/2026 1086893209 CMS
Novartis Pharmaceuticals Corporation $8.95 03/22/2024 Food and Beverage Undisputed 01/23/2026 1086893211 CMS
Novartis Pharmaceuticals Corporation $10.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 1086893207 CMS
Novartis Pharmaceuticals Corporation $12.47 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086893221 CMS
Novartis Pharmaceuticals Corporation $6.36 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086893227 CMS
Novartis Pharmaceuticals Corporation $16.39 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086893229 CMS
Novartis Pharmaceuticals Corporation $8.17 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086893223 CMS
Novartis Pharmaceuticals Corporation $19.24 05/10/2024 Food and Beverage Undisputed 01/23/2026 1086893225 CMS
Novartis Pharmaceuticals Corporation $21.21 06/21/2024 Food and Beverage Undisputed 01/23/2026 1086893235 CMS
Novartis Pharmaceuticals Corporation $2.72 07/19/2024 Food and Beverage Undisputed 01/23/2026 1086893241 CMS
Novartis Pharmaceuticals Corporation $17.55 07/19/2024 Food and Beverage Undisputed 01/23/2026 1086893243 CMS
Novartis Pharmaceuticals Corporation $12.31 07/30/2024 Food and Beverage Undisputed 01/23/2026 1086893239 CMS
Novartis Pharmaceuticals Corporation $10.80 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086893249 CMS
Novartis Pharmaceuticals Corporation $10.24 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086893251 CMS
Novartis Pharmaceuticals Corporation $19.82 10/18/2024 Food and Beverage Undisputed 01/23/2026 1086893265 CMS
Novartis Pharmaceuticals Corporation $16.66 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086893267 CMS
Novartis Pharmaceuticals Corporation $6.75 12/06/2024 Food and Beverage Undisputed 01/23/2026 1086893269 CMS
Novartis Pharmaceuticals Corporation $17.74 12/06/2024 Food and Beverage Undisputed 01/23/2026 1086893271 CMS
Novartis Pharmaceuticals Corporation $12.14 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086893273 CMS
PFIZER INC. $15.66 11/11/2024 Food and Beverage Undisputed 01/23/2026 1131002411 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.